John Schieszer

A review of what researchers are finding about “chemobrain,” a common adverse effect experienced by patients receiving chemotherapy for cancer.

Nurses at the forefront of telehealth practices share their views on how technology is expanding the reach of clinicians, improving cancer care for patients, and the barriers yet to be overcome.

A team of researchers sought to determine if BWH Tumor Classification System classified tumors more accurately than AJCC 8, and their sensitivity and specificity for predicting poor outcomes.

Oncology nurses discuss the importance of ongoing education on the treatments, symptoms, and available information on MPNs for patients, and oncology nurses.

A pilot study revealed the effectiveness of the DLQI in assessing quality of life measures in women with breast cancer treatment-related radiodermatitis.

These study results illustrate a need to educate survivors of childhood cancers on an ongoing potential risk for venous thromboembolism (VTE) beyond 5 years postdiagnosis.

Men who receive androgen deprivation therapy after radical prostatectomy have a nearly 2-fold increased risk of depression compared with those who receive no post-surgical treatment.

A randomized trial sought to measure the effect of educational modules on nurse use of personal protection equipment when handling and/or administering chemotherapy.

Researchers conducted a meta-analysis to determine the incidence of adverse events among patients assigned to placebo-receiving groups in randomized clinical trials.

In a study from the Cleveland Clinic, researchers investigated the association between well-differentiated thyroid cancer and risk for AML or CML in those patients treated with radioactive iodine.